Denmark· DK-28101041080

Heparin "Leo"

A heparin product containing heparinnatrium, registered in Denmark by LEO Pharma A/S. The same ATC class is registered in 12 of our 19 countries.

ATC B01AB01

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedHeparin "Leo"ATCB01AB01REGISTER NO.DK-28101041080PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Heparin is registered in 12 of 19 countries.

Countries holding a registration under ATC B01AB01 (heparin), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 8 of them publish a price we can compare per daily dose

Heparin · ATC B01AB01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Heparinnatrium
Manufacturer
LEO Pharma A/S
Country
Denmark (DK)
ATC code
B01AB01
ATC class
Heparin
Defined daily dose
10 TSD, E
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28101041080

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

714 interactions on record for heparin.

Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Heparin · interactions on record

714 records

  • 63 severe
  • 133 moderate
  • 18 minor
  • 500 info

Most severe, free to view

  • InotersenN07XX15severe
  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d8a49321-eeb5-4028-9942-596e7bfa34d2
GET /v1/drugs/d8a49321-eeb5-4028-9942-596e7bfa34d2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, opløsning",
  "source": "dkma",
  "strength": "1.000 IE/ml",
  "auth_role": "DKMA",
  "dk_drugid": "28101041080",
  "substance": "Heparinnatrium",
  "auth_procedure": "National",
  "in_medicinpriser": true,
  "registration_date_serial": "29396"
}

See everything about heparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.